Back to search results

Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial

Abroad (travel likely)RecruitingPHASE4

Conditions

Locally Advanced Bladder Urothelial Carcinoma · Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma · Metastatic Bladder Urothelial Carcinoma · Metastatic Renal Pelvis and Ureter Urothelial Carcinoma · Stage III Bladder Cancer AJCC v8 · Stage IV Bladder Cancer AJCC v8 · Stage IV Renal Pelvis and Ureter Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Principal Investigator (Jacob Orme, MD, PhD)
    Contact: Principal Investigator (Paras Shah, MD)
Study leads

  • Jacob J. Orme, MD, PhD

    Principal Investigator

    Mayo Clinic in Rochester

  • Paras H. Shah, MD

    Principal Investigator

    Mayo Clinic in Rochester

View source on ClinicalTrials.gov(opens in a new tab)